Captor Therapeutics, PLCPTRT00014

Captor Therapeutics stock stays near PLN 71.50

Published on 09/04/2026 at 20:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Captor Therapeutics stock is trading at PLN 71.50, with market value and biotech metrics still shaping the move.

Captor Therapeutics, PLCPTRT00014, Illustration mit AI erstellt.
Captor Therapeutics, PLCPTRT00014, Illustration mit AI erstellt.

Captor Therapeutics (PLCPTRT00014) closed at PLN 71.50 on September 3, 2026, after a 0.70 percent move and a market capitalization of PLN 452.838 million.

Market value in focus

The Warsaw listing on Yahoo Finance also showed a 52-week range of PLN 0.00 to PLN 0.00?

Biotech profile

Recent market data put the company in biotechnology, with no fresh operating figures in the visible snapshot, while the share price stayed close to the latest quoted level.

Product angle

The company develops oncology-focused therapies, and that pipeline remains the main driver of investor attention.

Stock level

Captor Therapeutics stock was last quoted at PLN 71.50 on September 3, 2026, with the market capitalization at PLN 452.838 million.

Captor Therapeutics at a glance

  • Company: Captor Therapeutics Spolka Akcyjna
  • ISIN: PLCPTRT00014
  • Ticker: CTT
  • Trading venue: Warsaw Stock Exchange
  • Price (as of September 3, 2026): PLN 71.50
  • Market capitalization: PLN 452.838 million (as of September 3, 2026)
  • Sector / Industry: Biotechnology

Disclaimer...

en | PLCPTRT00014 | CAPTOR THERAPEUTICS | boerse | 70056232 | bgmi